Home/Filings/4/0001493152-23-042666
4//SEC Filing

Diaz Stephanie 4

Accession 0001493152-23-042666

CIK 0001357459other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:00 PM ET

Size

8.4 KB

Accession

0001493152-23-042666

Insider Transaction Report

Form 4
Period: 2023-11-21
Transactions
  • Award

    Restricted Stock Units

    2023-11-21+5,8205,820 total
    Common Stock (5,820 underlying)
  • Award

    Common Stock Options

    2023-11-21+6,8806,880 total
    Exercise: $0.59Exp: 2033-11-21Common Stock (6,880 underlying)
Footnotes (5)
  • [F1]Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee.
  • [F2]The grants vest fully on the one (1) year anniversary of the grant date.
  • [F3]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  • [F4]N/A.
  • [F5]Each option represents the right to purchase one share of common stock at the exercise price.

Documents

1 file

Issuer

PALISADE BIO, INC.

CIK 0001357459

Entity typeother

Related Parties

1
  • filerCIK 0001850265

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:00 PM ET
Size
8.4 KB